CIAS
CBIZ Investment Advisory Services Portfolio holdings
AUM
$2.26B
1-Year Return
12.28%
This Quarter Return
+5.84%
1 Year Return
+12.28%
3 Year Return
+37%
5 Year Return
+55.03%
10 Year Return
–
AUM
$1.44B
AUM Growth
+$125M
(+9.5%)
Cap. Flow
+$47.6M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
92.6%
Holding
359
New
314
Increased
21
Reduced
11
Closed
2
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
$36.7M |
| 2 |
Vanguard Mid-Cap ETF
VO
|
$28.8M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$13.2M |
| 4 |
Vanguard Value ETF
VTV
|
$7.13M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$2.09M |
Top Sells
| 1 |
Vanguard Small-Cap ETF
VB
|
$25.1M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
$15.7M |
| 3 |
Vanguard Russell 1000 ETF
VONE
|
$10.3M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
$1.25M |
| 5 |
Cisco
CSCO
|
$430K |
Sector Composition
| 1 | Industrials | 2.67% |
| 2 | Technology | 0.47% |
| 3 | Financials | 0.16% |
| 4 | Healthcare | 0.1% |
| 5 | Communication Services | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Gabelli Dividend & Income Trust
GDV
$2.38B
| $2.3K | ﹤0.01% |
+100
| New | +$2.3K |
|
302
Nuveen Municipal Credit Income Fund
NZF
$2.32B
| $2.28K | ﹤0.01% |
+186
| New | +$2.28K |
|
303
MetLife
MET
$54.4B
| $2.24K | ﹤0.01% |
+30
| New | +$2.24K |
|
304
US Physical Therapy
USPH
$1.3B
| $2.18K | ﹤0.01% |
+192
| New | +$2.18K |
|
|
IGR
305
CBRE Global Real Estate Income Fund
IGR
$705M
| $2.15K | ﹤0.01% |
+400
| New | +$2.15K |
|
306
Eastman Chemical
EMN
$7.88B
| $2.12K | ﹤0.01% |
+21
| New | +$2.12K |
|
307
Starwood Property Trust
STWD
$7.52B
| $2.08K | ﹤0.01% |
+100
| New | +$2.08K |
|
308
Regeneron Pharmaceuticals
REGN
$60.1B
| $1.93K | ﹤0.01% |
+2
| New | +$1.93K |
|
309
Seagate
STX
$39.1B
| $1.88K | ﹤0.01% |
+20
| New | +$1.88K |
|
310
Enbridge
ENB
$105B
| $1.84K | ﹤0.01% |
+51
| New | +$1.84K |
|
311
Bristol-Myers Squibb
BMY
$95B
| $1.63K | ﹤0.01% |
+30
| New | +$1.63K |
|
312
UGI
UGI
$7.4B
| $1.6K | ﹤0.01% |
+65
| New | +$1.6K |
|
313
Gilead Sciences
GILD
$140B
| $1.48K | ﹤0.01% |
+20
| New | +$1.48K |
|
314
GE HealthCare
GEHC
$33.8B
| $1.46K | ﹤0.01% |
+16
| New | +$1.46K |
|
315
Kohl's
KSS
$1.84B
| $1.45K | ﹤0.01% |
+49
| New | +$1.45K |
|
316
Weyerhaeuser
WY
$18.4B
| $1.42K | ﹤0.01% |
+39
| New | +$1.42K |
|
317
Estee Lauder
EL
$31.5B
| $1.39K | ﹤0.01% |
+9
| New | +$1.39K |
|
318
Kenvue
KVUE
$39.4B
| $1.39K | ﹤0.01% |
+65
| New | +$1.39K |
|
319
Clearway Energy Class C
CWEN
$3.38B
| $1.31K | ﹤0.01% |
+57
| New | +$1.31K |
|
320
Pitney Bowes
PBI
$2.11B
| $1.28K | ﹤0.01% |
+295
| New | +$1.28K |
|
321
SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.41B
| $1.27K | ﹤0.01% |
+26
| New | +$1.27K |
|
322
Danaher
DHR
$143B
| $1.25K | ﹤0.01% |
+5
| New | +$1.25K |
|
323
DNP Select Income Fund
DNP
$3.66B
| $1.24K | ﹤0.01% |
+137
| New | +$1.24K |
|
324
AB InBev
BUD
$116B
| $1.24K | ﹤0.01% |
+20
| New | +$1.24K |
|
325
Kraft Heinz
KHC
$31.9B
| $1.15K | ﹤0.01% |
+31
| New | +$1.15K |
|